United StatesGlycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz (473 mL), Rx only (NDC 72205-070-72), manufactured by MSN Pharmaceuticals and distributed by Novadoz Pharmaceuticals, is affected — lot numbers CB2505159A and CB2505160A (exp. 04/2027) and CB2505161A (exp. 05/2027). Novadoz is recalling these products nationwide in the United States because they failed impurities/degradation specifications.
What's being recalled
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
Recalling firm: Novadoz Pharmaceuticals LLC, Piscataway, NJ, United States.
How to identify it
Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
The hazard
Failed Impurities/Degradation Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)